Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 10, 2026 09:00 ET | Source: Truveta

FDA cardiovascular indication for semaglutide led to short-term uptake but persistent treatment gaps among high-risk patients, new Truveta study finds

BELLEVUE, Wash., Feb. 10, 2026 (GLOBE NEWSWIRE) -- A new peer-reviewed study led by Truveta Research and collaborators finds that the US Food and Drug Administration’s (FDA) March 2024 expansion of...
February 09, 2026 09:00 ET | Source: Truveta

Truveta deepens regulatory science leadership with appointment of John D. Seeger, PharmD, DrPH, FISPE as Senior Vice President of Evidence Services

BELLEVUE, Wash., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Truveta today announced the appointment of John D. Seeger, PharmD, DrPH, FISPE, a global leader in pharmacoepidemiology, to lead Truveta Evidence...
January 27, 2026 09:00 ET | Source: Truveta

Truveta launches real-time clinical trials solution to accelerate study design, enrollment, and evidence generation

BELLEVUE, Wash., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Truveta today announced the launch of its new clinical trials solution that enables trial sponsors to design, optimize, and execute clinical...
January 26, 2026 09:00 ET | Source: Truveta

Truveta deepens oncology and scientific leadership with appointment of Johnathan Lancaster, MD, PhD as President and Chief Scientific Officer

BELLEVUE, Wash., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Truveta today announced the appointment of Johnathan M. Lancaster, MD, PhD as President and Chief Scientific Officer, deepening the company’s...
November 14, 2025 11:19 ET | Source: Truveta

Truveta research published in JAMA Network Open shows rapid uptake of early measles vaccination during Texas outbreak

BELLEVUE, Wash., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Truveta’s analysis of early measles, mumps, and rubella (MMR) vaccinations among Texas infants published today in JAMA Network Open. The study...
September 23, 2025 09:00 ET | Source: Truveta

Regulatory-grade device evidence reimagined with new precision data from Truveta

BELLEVUE, Wash., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Truveta today announced a major expansion of its real-world device data capabilities, giving device manufacturers and regulators the most...
March 26, 2025 09:00 ET | Source: Truveta

New administrative data in Truveta Data and features in Truveta Studio help researchers accelerate regulatory grade research

BELLEVUE, Wash., March 26, 2025 (GLOBE NEWSWIRE) -- Today, Truveta announced that Truveta Data has expanded to include new administrative data to enable more comprehensive analyses of healthcare...
February 13, 2025 09:00 ET | Source: Truveta

Truveta Data expands beyond EHR data with linked closed claims for more than 200 million patients

BELLEVUE, Wash., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Today, Truveta announced the expansion of Truveta Data with the addition of new commercial, Medicare, and Medicaid closed claims on more than 200...
November 20, 2024 09:00 ET | Source: Truveta

Truveta achieves HITRUST r2 Certification, demonstrating the highest level of information protection assurance

BELLEVUE, Wash., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Truveta announced that its platform Truveta Studio and Truveta Data have earned certified status by HITRUST for information security. This...
November 14, 2024 09:53 ET | Source: Truveta

Truveta Data, the most complete, timely, and clean electronic health record data, now includes more than 120 million de-identified patients

BELLEVUE, Wash., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Truveta announced today that Truveta Data, the most complete, timely, and clean electronic health record (EHR) data, now includes more than 120...